Dysphagia Management Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Dysphagia Management Market Trends and Insights

Aging and Neurological Disease Burden

Aging populations provide a stable demand base for the dysphagia management market, as swallowing impairments often require ongoing clinical and nutritional support. Inpatient rehabilitation evidence published in 2024 found that 33% of older patients with dysphagia developed aspiration pneumonia.^{[2]Rainer Dziewas et al., “Complications of Oropharyngeal Dysphagia in Older Individuals and Interventions to Reduce Their Risk,” Frontiers in Neurology, frontiersin.org} The same evidence reported malnutrition rates of 25% to 45% among dysphagia patients across the reviewed cohorts. Sarcopenia was associated with dysphagia, with a corrected odds ratio of 4.1 and a 95% confidence interval of 2.3 to 7.3. In 2025, low-income countries had up to 82 times fewer neurologists per 100,000 residents than high-income countries, which can delay diagnosis and treatment. Therefore, the dysphagia management market benefits from integrated nutritional rehabilitation and swallowing care for older patients with neurological diseases.

Earlier Dysphagia Screening and Instrumental Assessment

Hospitals are placing greater emphasis on instrumental assessment because bedside reviews can fail to identify silent aspiration. A 2025 review found continued gaps in psychometric evidence for dysphagia screening tools used with older adults. This limitation supports demand for sensor-based and AI-assisted alternatives to water swallowing tests within the Dysphagia management market. The 2025 UEG and ESGNM clinical recommendations identified videofluoroscopic swallow study and fiberoptic endoscopic evaluation of swallowing as first-line assessments for oropharyngeal and esophageal dysphagia. A 2025 survey found that 81.4% of U.S. speech-language pathologists had access to imaging assessments, although protocol use varied among younger clinicians.^{[3]American Speech-Language-Hearing Association, “Use of Standardized Dysphagia Protocols in Clinical Practice A Survey of U.S. Speech-Language Pathologists,” Journal of Speech, Language, and Hearing Research, pubs.asha.org} Hospitals also have a financial reason to improve screening, where pneumonia readmissions can affect performance under federal payment programs.

Expansion of Home-Based and Post-Acute Dysphagia Care

Home-based rehabilitation and enteral nutrition are increasing the need for care models that support patients after discharge. The dysphagia management market benefits from portable systems that enable caregivers to manage feeding under clinical oversight. In September 2025, the National Home Infusion Association reported that one in four enteral nutrition providers was considering or planning to exit the supply business because of reimbursement conditions. Commercial insurers covered 38.3% of home enteral nutrition users, while Medicare fee-for-service and dual-eligible patients accounted for 34.1%. This payer mix complicates purchasing and formulary decisions for suppliers and providers. In May 2024, Rockfield Medical Devices received FDA over-the-counter clearance for its Mobility+ Enteral Feeding System, reflecting the shift toward portable devices that may reduce prescription-related access barriers.

IDDSI Standardization of Texture and Liquid Consistency

The IDDSI framework is turning texture and fluid consistency into a product compliance issue across care settings. Singapore made IDDSI adherence a licensing requirement for care facilities under the Healthcare Services Act from August 2024. The Dysphagia management market is affected because facilities must use the required texture and fluid levels and document suitable alternative diets when primary levels are unavailable. IDDSI released Framework V2.2 in April 2026, updating testing methods and food level descriptions. Manufacturers must validate existing products and may need to reformulate them under the updated framework. A 2026 Swedish mixed-methods study found that structured implementation improved meal compliance across all IDDSI texture levels. The former U.S. National Dysphagia Diet had already been fully superseded by IDDSI since October 2021, leaving suppliers with continuing validation work.

Reimbursement and Coverage Variability

Coverage differences across Medicare contractors, Medicare Advantage plans, and state Medicaid programs can limit the use of newer assessment tools and specialist services. ASHA reported in 2025 that speech-language pathologists faced delayed or inconsistent Medicare Advantage payments, while utilization management practices reduced access for some beneficiaries. The dysphagia management market also faces supplier pressure in home enteral nutrition. The number of Medicare suppliers offering home enteral nutrition kits declined 31% from 2014 to 2023 under competitive bidding pressure.^{[4]National Home Infusion Association, “Trends in Home Enteral Nutrition The Impact of Competitive Bidding on Access and Quality,” NHIA White Paper, nhia.org} Texture-modified retail nutrition is not uniformly reimbursed across Europe, and several health systems cap speech therapy reimbursement. Coverage requirements for swallowing studies add administrative work that is harder for smaller providers to manage. These conditions favor organizations with broader clinical networks and established reimbursement capabilities.

Shortage of Trained Dysphagia Specialists

Dysphagia care depends on speech-language pathologists who assess patients, guide rehabilitation, and determine care pathways. In ASHA’s 2025 survey, 55.5% of healthcare respondents said job openings exceeded job seekers at their facilities. The survey also found funded but unfilled positions at 44.8% of facilities, despite a 3.3% annual increase in ASHA-certified speech-language pathologists to 212,864 by the end of 2024. The gap is especially relevant to home health, rural care, and underserved settings. A limited specialist workforce can slow the adoption of advanced products in the dysphagia management market, where clinical judgment remains central. Digital rehabilitation and AI-assisted screening can support lower-acuity cases, but complex mixed dysphagia continues to require direct specialist involvement.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Product Type: Nutritional Solutions Support Institutional and Home Care

Nutritional solutions held 41.22% of the dysphagia management market share in 2025, reflecting the use of thickeners, texture-modified foods, and enteral formulas in institutional and home settings. A 2026 study found that starch-based products lost more than 99% of viscosity within 5 seconds of salivary alpha-amylase exposure, whereas xanthan gum products showed a 1% to 20% reduction.^{[5]P. García-Peris et al., “Salivary Alpha-Amylase Time-Effect on Thickening Products,” PubMed Central, pmc.ncbi.nlm.nih.gov} This distinction can affect aspiration risk and clinical purchasing decisions. Fresenius Kabi expanded its Fresubin plant-based range during 2025 and 2026.

Feeding tubes and devices were the second-largest category, supported by nasogastric and gastrostomy placement in hospitals and nutrition centers. Drugs were the fastest-growing category through 2031 as pharmacological protocols expanded for esophageal dysphagia. Proton pump inhibitors, corticosteroids, and antimicrobials were included in the supplied treatment scope.

By Indication: Oropharyngeal Dysphagia Drives Broad Care Demand

Oropharyngeal dysphagia held 62.18% of the dysphagia management market share in 2025, consistent with its prevalence in stroke, neurodegenerative disease, and age-related swallowing decline. It requires nutritional modification, assessment, and rehabilitation across several care settings. A June 2026 study in Catalonia identified polypharmacy and poor baseline nutritional status as independent risk factors in older adults. These findings extend the relevant patient group beyond conventional stroke and dementia cohorts.

Esophageal dysphagia has a separate pathway that involves endoscopy, dilation, and pharmacological treatment. The 2025 UEG and ESGNM recommendations included proton pump inhibitors, calcium-channel blockers, and phosphodiesterase inhibitors for specific subtypes. Mixed and multifactorial dysphagia was the fastest-growing indication through 2031 as overlapping oral, pharyngeal, and esophageal dysfunction became more recognized. A July 2026 study compared the Medtronic ManoScan ESO and Laborie LMT systems for standardized swallow pressure measurement.

By Age Group: Geriatric Care Holds the Largest Revenue Base

The geriatric group represented 64.33% of revenue in 2025 and was the largest age cohort in the Dysphagia management market. It was also the fastest-growing age group through 2031. Geriatric patients often require texture-modified meals, enteral nutrition, and continuing speech therapy. Sarcopenia was associated with dysphagia at a corrected odds ratio of 4.1, supporting combined nutritional rehabilitation, resistance exercise, and swallowing therapy.

Adults represented the second-largest revenue pool, driven by stroke, head and neck cancer, and surgical complications. They also required more instrumental swallowing assessments. Pediatric patients were the smallest cohort by revenue but required age-specific formulas, pediatric feeding tubes, and palatability-focused oral supplements. Nestlé Health Science launched Complete Pediatric Oral Blends in 7 European countries during February 2026, using fruit, rice, and pea proteins.

By End User: Hospitals Lead, While Homecare Grows Fastest

Hospitals and ambulatory surgical centers held 36.11% of revenue in 2025, making them the leading end-user setting in the Dysphagia management market. These sites manage acute diagnosis, instrumental assessment, and initial nutritional treatment. Access to VFSS and FEES systems, multidisciplinary swallowing teams, and formulary purchasing support their role. Long-term care, rehabilitation, and outpatient clinics manage continuing nutrition, device use, therapy, and reassessment.

Homecare settings were the fastest-growing end-user category through 2031. Portable feeding equipment, telehealth, and remote monitoring support care after discharge. The NHIA reported in 2025 that 1 in 4 enteral nutrition providers were considering leaving the home enteral nutrition supply business because of reimbursement conditions. This supply constraint may restrict the full potential of homecare expansion.

Geography Analysis

North America held 41.21% of global revenue in 2025, supported by established speech-language pathology networks and hospital formulary systems. The United States had 61.9 certified speech-language pathologists per 100,000 residents in 2025. Availability ranged from 33.4 per 100,000 in Nevada to 101.0 per 100,000 in Arkansas.^{[6]American Speech-Language-Hearing Association, “Supply and Demand Resource List for Speech-Language Pathologists,” ASHA, asha.org} Canada broadly reimburses speech therapy and enteral nutrition for diagnosed patients. Mexico is expanding as private hospital networks increase geriatric care capacity.

Europe was the second-largest region, with Germany, the United Kingdom, France, Italy, and Spain as major institutional markets. Germany’s statutory insurance system supports hospital and home enteral nutrition reimbursement. The United Kingdom’s NHS procurement model emphasizes clinical evidence and pricing compliance. UEG and ESGNM recommendations are supporting endoscopy investment, while structured IDDSI programs in Sweden and Austria create validation needs. Brazil is expanding with geriatric population growth and urban hospital capacity, though screening remains uneven outside major centers.

Asia-Pacific was the fastest-growing region at a 6.55% CAGR through 2031, supporting growth in the Dysphagia management market size. Japan’s long-term care insurance supports eligible older patients using texture-modified nutrition. China is expanding rehabilitation and geriatric facilities, while South Korea is developing remote monitoring-based home feeding. India is building specialist capacity, and Australia has adopted IDDSI early with acute stroke screening protocols. GCC investment supports Middle East and Africa growth, but specialist shortages and import costs restrict wider adoption in Sub-Saharan Africa.